News

  1. Eight promising medtech companies receive seed funding, training and mentoring from venture-backed national accelerator: The Actuator – Australia’s National Medtech Catalyst

    Summary: The Actuator are thrilled to announce the eight high-impact medtech startups that are part of the 2018 Round 2 Actuator Accelerator program: TerraBlue XT, Curatek, Stelect, Augmented Bionics, ElectroAutoMedics, Flomatrix, Hexagon Innovation and Lenexa Medical. The Actuator’s second cohort of companies will be put through their paces in a rigorous industry-led 15-month program, which will…

  2. Female-led startup commercialising novel stent size selection device takes out the top prize in MedTech’s Got Talent

    Summary: Stelect, a female-led, Victorian startup commercialising a novel coronary stent size selection device, has taken out the top prize for the 4th cohort of MedTech’s Got Talent. STC Australia and The Actuator are excited to announce that the $40,000 top prize for MedTech’s Got Talent has been awarded to Fay Gibson, Elise Sutherland, Elizabeth…

  3. Life Sciences 4.0: Securing value through data-driven platforms

    Life sciences companies at risk of falling behind technology competitors in race to address evolving consumer demands New EY report looks at effect of consumerism and affordability on the life sciences industry  More than 75% of life sciences Fortune 500 companies may fall out of ranking by 2023, due to increasing competition and industry convergence…

  4. Have You Got What It Takes? Actuator Accelerator Applications For Round 2, 2018 Now Open!

    APPLICATIONS FOR THE ACTUATOR JULY COHORT ARE NOW OPEN! Utilising a 15-month focused industry-led curriculum, The Actuator Accelerator Program will take Seed ventures to Series A investment; leading into clinical trials, advanced manufacturing, and at-scale technology deployment. Through intensive mentorship, industry collaboration, and value-network support, our startups can achieve in 15 months what can typically…

  5. WHEN AUSTRALIA INNOVATES, THE WORLD OF HEALTHCARE CHANGES

    A higher risk tolerance for investment in the ‘deep tech startup’ space and fragmentation across the sector must be addressed if Australian MedTech is to be taken seriously on the world stage according to a new MedTech Discussion Paper launched today. The paper, launched by The Honourable Matt Kean MP, Minister for Innovation and Better…

  6. Have You Got What It Takes? Actuator Accelerator Applications For Round 1, 2018 Now Open!

    ABOUT THE ACTUATOR The first of its kind, The Actuator is a deeply collaborative national program that gives promising early-stage medical technology companies an accelerated pathway to $2.7 million of funding, capitalising on Australia’s strengths in medical research, healthcare, clinical trials and advanced manufacturing. We’re about real markets, real needs, real healthcare and real experts….

  7. Taking Medtech All The Way To Silicon Valley

    Meet the Melbourne clinicians reading brain signals to help the paralysed move A minimally-invasive technology that transmits brain signals to wheelchairs, bionic arms or other devices could help those with amputations, paralysis or multiple sclerosis to move again. Called the stentrode, the device can be delivered via a blood vessel in the neck—meaning patients don’t…

  8. The Actuator Accelerator Has Launched!

    Reading brain signals to help the paralysed move and more—The Actuator taking Australia’s promising medical technologies to market Australian medtech start-ups will each have access to up to $4 million under a national program launched today. The Actuator brings together leading players from across Australia’s medical technology innovation ecosystem, and is the first in a…